Literature DB >> 18832570

Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.

Tai-Lan Tuan1, Paul Hwu, Wendy Ho, Peter Yiu, Richard Chang, Annette Wysocki, Paul D Benya.   

Abstract

Keloids are tumor-like skin scars that grow as a result of the aberrant healing of skin injuries, with no effective treatment. We provide new evidence that both overexpression of plasminogen activator inhibitor-1 (PAI-1) and elevated collagen accumulation are intrinsic features of keloid fibroblasts and that these characteristics are causally linked. Using seven strains each of early passage normal and keloid fibroblasts, the keloid strains exhibited inherently elevated collagen accumulation and PAI-1 expression in serum-free, 0.1% ITS+ culture; larger increases in these parameters occurred when cells were cultured in 3% serum. To demonstrate a causal relationship between PAI-1 overexpression and collagen accumulation, normal fibroblasts were infected with PAI-1-expressing adenovirus. Such cells exhibited a two- to fourfold increase in the accumulation of newly synthesized collagen in a viral dose-dependent fashion in both monolayers and fibrin gel, provisional matrix-like cultures. Three different PAI-1-targeted small interfering RNAs, alone or in combination, produced greater than an 80% PAI-1 knockdown and reduced collagen accumulation in PAI-1-overexpressing normal or keloid fibroblasts. A vitronectin-binding mutant of PAI-1 was equipotent with wild-type PAI-1 in inducing collagen accumulation, whereas a complete protease inhibitor mutant retained approximately 50% activity. Thus, PAI-1 may use more than its protease inhibitory activity to control keloid collagen accumulation. PAI-1-targeted interventions, such as small interfering RNA and lentiviral short hairpin RNA-containing microRNA sequence suppression reported here, may have therapeutic utility in the prevention of keloid scarring.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832570      PMCID: PMC2570122          DOI: 10.2353/ajpath.2008.080272

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts.

Authors:  L J Meyer; S B Russell; J D Russell; J S Trupin; B M Egbert; S Shuster; R Stern
Journal:  J Invest Dermatol       Date:  2000-05       Impact factor: 8.551

Review 2.  Targeted therapy comes of age in scleroderma.

Authors:  Christopher P Denton; Carol M Black
Journal:  Trends Immunol       Date:  2005-09-15       Impact factor: 16.687

3.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

4.  Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts.

Authors:  J Uitto; A J Perejda; R P Abergel; M L Chu; F Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures.

Authors:  R P Abergel; D Pizzurro; C A Meeker; G Lask; L Y Matsuoka; R R Minor; M L Chu; J Uitto
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

6.  Alteration of amino acid transport by hydrocortisone. Different effects in human fibroblasts derived from normal skin and keloid.

Authors:  S B Russell; J D Russell; J S Trupin
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

7.  A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.

Authors:  Yanhui Chu; Fen Guo; Yueqin Li; Xiaokun Li; Tianhong Zhou; Yanqin Guo
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

8.  Identification of unique gene expression patterns within different lesional sites of keloids.

Authors:  Oliver Seifert; Ardeshir Bayat; Robert Geffers; Kirstin Dienus; Jan Buer; Sture Löfgren; Andreas Matussek
Journal:  Wound Repair Regen       Date:  2008-02-13       Impact factor: 3.617

9.  Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth.

Authors:  S B Russell; K M Trupin; S Rodríguez-Eaton; J D Russell; J S Trupin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

10.  Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.

Authors:  J Keski-Oja; R Raghow; M Sawdey; D J Loskutoff; A E Postlethwaite; A H Kang; H L Moses
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

View more
  16 in total

1.  Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions.

Authors:  Vanina Monique Tucci-Viegas; Bernardo Hochman; Jerônimo P França; Lydia M Ferreira
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

2.  siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I.

Authors:  Masayo Aoki; Koichi Miyake; Rei Ogawa; Teruyuki Dohi; Satoshi Akaishi; Hiko Hyakusoku; Takashi Shimada
Journal:  J Invest Dermatol       Date:  2013-09-16       Impact factor: 8.551

3.  Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healing.

Authors:  Paweł Olczyk; Katarzyna Komosińska-Vassev; Katarzyna Winsz-Szczotka; Ewa M Koźma; Grzegorz Wisowski; Jerzy Stojko; Katarzyna Klimek; Krystyna Olczyk
Journal:  J Zhejiang Univ Sci B       Date:  2012-11       Impact factor: 3.066

Review 4.  PAI-1 in tissue fibrosis.

Authors:  Asish K Ghosh; Douglas E Vaughan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

5.  Epigenetically altered wound healing in keloid fibroblasts.

Authors:  Shirley B Russell; James D Russell; Kathryn M Trupin; Angela E Gayden; Susan R Opalenik; Lillian B Nanney; Alan H Broquist; Latha Raju; Scott M Williams
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

6.  Contracting scars from fibrin drops.

Authors:  Stephen Robinson; Eric Parigoris; Jonathan Chang; Louise Hecker; Shuichi Takayama
Journal:  Integr Biol (Camb)       Date:  2022-03-21       Impact factor: 3.177

7.  Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.

Authors:  Anna I Arno; Saeid Amini-Nik; Patrick H Blit; Mohammed Al-Shehab; Cassandra Belo; Elaine Herer; Marc G Jeschke
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

8.  Expressions of Collagen I and III in Hypoxic Keloid Tissue.

Authors:  Endah Wulandari; Sri Widia A Jusman; Yefta Moenadjat; Ahmad A Jusuf; Mohamad Sadikin
Journal:  Kobe J Med Sci       Date:  2016-07-25

Review 9.  Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.

Authors:  Carmel B Nanthakumar; Richard J D Hatley; Seble Lemma; Jack Gauldie; Richard P Marshall; Simon J F Macdonald
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

10.  Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling.

Authors:  Kevin J Ashcroft; Farhatullah Syed; Ardeshir Bayat
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.